Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

All Content

  • 1
    News

    EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients

    November 17, 2021

    A landmark trial proved empagliflozin’s efficacy in HFpEF, but many patients had “moderately reduced” EFs. The findings hold up even without them.

  • 1
    News

    Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT

    November 17, 2021

    The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a phase 3 trial.

  • 1
    News

    Comparing pulmonary embolism mortality risk scores 

    November 16, 2021

    How well do risk scores estimate mortality outcomes in patients with acute pulmonary embolism (PE)? 

  • 1
    News

    EHRs have no impact on inpatient heart failure clinical choices or outcomes

    November 15, 2021

    Relative to usual care, prognostic information at the bedside provided no advantage for heart failure care.

  • 1
    News

    Troponin elevation at any age is a risk for cardiac mortality

    November 15, 2021

    Is an elevated troponin value associated with increased mortality, regardless of age?

  • 1
    News

    BP Track: Blood pressure control rates dropped during pandemic

    November 14, 2021

    Data culled from 24 health systems showed lower rates of blood pressure control during the COVID-19 pandemic.

  • 1
    News

    Pandemic innovations that will outlast COVID

    November 11, 2021

    Hospitalists discuss process changes implemented during the pandemic that will likely survive it.

  • 1
    Opinion

    What does it mean to be a trustworthy male ally?

    November 10, 2021

    “I began to understand that graceful self-promotion is not optional for many women in medicine, it is a necessary skill.”

  • News

    Regeneron’s antibody drug shows protection against COVID-19 for up to 8 months

    November 10, 2021

    Such immunity is particularly important for immunocompromised people and those not responding to vaccines.

  • News

    Unvaccinated people 20 times more likely to die from COVID: Texas study

    November 10, 2021

    “The COVID-19 vaccines are doing an excellent job of protecting people from getting sick and from dying from COVID-19.”

Previous1 … 6 7 8 9 10 … 861Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences